Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide

Antisense oligonucleotide-based (ASO) therapeutics have emerged as a promising strategy for the treatment of human disorders. Charge-neutral PMOs have promising biological and pharmacological properties for antisense applications. Despite their great potential, the efficient delivery of these therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Haque, Umme Sabrina, Yokota, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572411/
https://www.ncbi.nlm.nih.gov/pubmed/37830609
http://dx.doi.org/10.3390/cells12192395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572411/
https://www.ncbi.nlm.nih.gov/pubmed/37830609
http://dx.doi.org/10.3390/cells12192395

Ejemplares similares